The results of zymography assays showed that the EFEMP1 protein variant expressed from construct E5 significantly inhibited U251-NS glioma cells from making activated MMP2, whereas the wild-type EFEMP1 and EFEMP1 variants expressed from constructs E1, E15, and E18 significantly promoted this activity. Here, EFEMP1 is linked to central nervous system cancer.